Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Add-on to Rabeprazole Triple Therapy for H. pylori
NCT03108287Phase 4Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- DNA Intercalators/Alkylators
01
Overview
Phase 4, randomised, open-label trial of bismuth subcitrate in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Rate of H. pylori eradication. Started Apr 2013; status: completed.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03108287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03108287.